Breast Cancer Clinical Trials in Michigan

Showing 441-460 of 478 trials

The Effects of Pre-operative Physical Therapy Education

NCT01669187

It is expected that patients who receive physical therapy before surgery will have greater range of motion (ROM), strength, function, satisfaction, and less swelling, pain, and anxiety following surgery compared to those in the control group.

Breast Cancer

Oakland UniversityStarted Dec 2011

Saginaw, Michigan, United States • Saginaw, Michigan, United States

COMPLETEDPhase 354 miles

S0012 Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Filgrastim in Treating Women With Inflammatory or Locally Advanced Breast Cancer

NCT00016406

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. It is not yet known whether combination chemotherapy is more effective with or without filgrastim in treating breast cancer. PURPOSE: Randomized phase III trial to compare the effectiveness of combining doxorubicin, cyclophosphamide, and paclitaxel with or without filgrastim in treating women who have inflammatory or locally advanced breast cancer.

Breast Cancer

SWOG Cancer Research Network399 participantsStarted May 2001

Mobile, Alabama, United States • Anchorage, Alaska, United States • Fairbanks, Alaska, United States +311 more locations

The Effects of Pre-operative Physical Therapy Education

S0012 Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Filgrastim in Treating Women With Inflammatory or Locally Advanced Breast Cancer

Breast Cancer Trials in Other Cities

Vinflunine Plus Trastuzumab in Human Epidermal Growth Factor Receptor 2 (HER2neu) Over-Expressing Metastatic Breast Cancer

S0102: Docetaxel, Vinorelbine, and Filgrastim in Treating Women With Stage IV Breast Cancer

S9630, Medroxyprogesterone in Treating Women With Breast Cancer

Chemotherapy Plus Monoclonal Antibody Therapy in Treating Women With Stage II or Stage IIIA Breast Cancer That Overexpresses HER2

A Study to Assess Capecitabine (Xeloda®) in Patients With Locally Advanced or Metastatic Breast Cancer

Nutrition Intervention in Treating Women With Breast Cancer

A Study to Evaluate the Efficacy and Safety of Herceptin® (Trastuzumab) in Combination With Arimidex® (Anastrozole) an Aromatase Inhibitor Compared to Arimidex® Alone in Patients With Metastatic Breast Cancer

Whole Brain Radiation Therapy With Oxygen, With or Without RSR13, in Women With Brain Metastases From Breast Cancer

S0511, Goserelin and Anastrozole in Treating Men With Recurrent or Metastatic Breast Cancer

A Prospective Cohort Study to Evaluate the Oncotype DX® Test in Early Stage Breast Cancer

Positron Emission Tomography/Computed Tomography (PET/CT) for the Diagnosis of Recurrent Cancer: a Feasibility Study

Magnetic Resonance Imaging in Women Receiving Chemotherapy for Stage III Breast Cancer

Breast Ultrasound and Mammography in Screening Women at High Risk for Breast Cancer

Trial to Evaluate the Therapeutic Benefit of Fulvestrant in Combination With ZACTIMA in Postmenopausal Women With Bone Predominant, Hormone Receptor Positive Metastatic Breast Cancer

A Phase 2 Trial of Standard Chemotherapy, With or Without BSI-201, in Patients With Triple Negative Metastatic Breast Cancer

A Study Evaluating the Efficacy and Safety of Bevacizumab in Combination With Chemotherapy in Untreated Metastatic Breast Cancer (RIBBON 1)

MRI-Guided Ultrasound Energy in Treating Patients With Stage I, Stage II, or Stage IIIA Breast Cancer

Microwave Thermotherapy in Treating Women With Stage I or Stage II Breast Cancer

Other Conditions in Michigan